Investing
Investing Cash Flow
Vertex Pharmaceuticals Investing Cash Flow decreased by 146.2% to -$288.10M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 64.9%, from -$821.90M to -$288.10M. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 40.5% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Typically negative for growing companies as they reinvest cash; a positive value suggests the company is liquidating assets faster than it is buying them.
Detailed definition
The aggregate sum of all cash inflows and outflows related to a company's long-term investments and capital assets. It s...
Peer comparison
Mature companies with high cash flow often show large negative values here as they recycle profits into new growth or financial instruments.
Metric ID:
cf_net_cash_from_investingHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$79.64M | -$52.95M | -$134.00M | -$51.00M | -$61.50M | -$384.20M | -$1.83B | -$303.90M | -$117.70M | -$886.50M | -$2.14B | -$463.70M | -$348.00M | -$821.90M | -$55.80M | -$484.50M | -$117.00M | -$288.10M |
| QoQ Change | — | +33.5% | -153.1% | +61.9% | -20.6% | -524.7% | -377.3% | +83.4% | +61.3% | -653.2% | -141.0% | +78.3% | +25.0% | -136.2% | +93.2% | -768.3% | +75.9% | -146.2% |
| YoY Change | — | — | — | — | +22.8% | -625.6% | <-999% | -394.1% | +69.4% | — | -16.5% | -52.6% | -195.7% | +7.3% | +97.4% | -4.5% | +66.4% | +64.9% |
Range-$2.14B – -$51.00M
CAGR+35.3%
Avg YoY Growth-342.8%
Median YoY Growth-4.5%
Investing Cash Flow at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's investing cash flow?
- Vertex Pharmaceuticals (VRTX) reported investing cash flow of -$288.10M in Q4 2025.
- How has Vertex Pharmaceuticals's investing cash flow changed year-over-year?
- Vertex Pharmaceuticals's investing cash flow increased by 64.9% year-over-year, from -$821.90M to -$288.10M.
- What is the long-term trend for Vertex Pharmaceuticals's investing cash flow?
- Over 3 years (2021 to 2025), Vertex Pharmaceuticals's investing cash flow has grown at a 40.5% compound annual growth rate (CAGR), from -$340.90M to -$945.40M.
- What does investing cash flow mean?
- The total net change in cash resulting from buying and selling long-term assets and investments.